103 related articles for article (PubMed ID: 37459055)
21. Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data.
Tranby EP; Heaton LJ; Tomar SL; Kelly AL; Fager GL; Backley M; Frantsve-Hawley J
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1849-1857. PubMed ID: 35732291
[TBL] [Abstract][Full Text] [Related]
22. Screening for Sexually Transmitted Infections After Cervical Cancer Screening Guideline and Medicaid Policy Changes: A Population-based Analysis.
Parekh N; Donohue JM; Corbelli J; Men A; Kelley D; Jarlenski M
Med Care; 2018 Jul; 56(7):561-568. PubMed ID: 29781922
[TBL] [Abstract][Full Text] [Related]
23. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas.
Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR
J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776
[TBL] [Abstract][Full Text] [Related]
24. Facilitators and barriers to cervical cancer screening, diagnosis, and enrollment in Medicaid: experiences of Georgia's Women's Health Medicaid Program enrollees.
Blake SC; Andes K; Hilb L; Gaska K; Chien L; Flowers L; Adams EK
J Cancer Educ; 2015 Mar; 30(1):45-52. PubMed ID: 24943328
[TBL] [Abstract][Full Text] [Related]
25. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries.
Liang Y; Rascati K; Richards K
Curr Med Res Opin; 2021 Aug; 37(8):1315-1322. PubMed ID: 33910428
[TBL] [Abstract][Full Text] [Related]
27. Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.
Franc BL; Copeland TP; Thombley R; Park M; Marafino B; Dean ML; Boscardin WJ; Rugo HS; Seidenwurm D; Sharma B; Johnston SR; Dudley RA
J Natl Compr Canc Netw; 2018 Jul; 16(7):829-837. PubMed ID: 30006425
[No Abstract] [Full Text] [Related]
28. Co-payment policies and breast and cervical cancer screening in Medicaid.
Sabik LM; Vichare AM; Dahman B; Bradley CJ
Am J Manag Care; 2020 Feb; 26(2):69-74. PubMed ID: 32059094
[TBL] [Abstract][Full Text] [Related]
29. Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.
Ginindza TG; Sartorius B
BMC Cancer; 2018 Jun; 18(1):639. PubMed ID: 29879943
[TBL] [Abstract][Full Text] [Related]
30. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
[TBL] [Abstract][Full Text] [Related]
31. The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age-Period-Cohort Analysis.
Shing JZ; Beeghly-Fadiel A; Griffin MR; Chang RS; Sudenga SL; Slaughter JC; Pemmaraju M; Mitchel EF; Hull PC
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439369
[TBL] [Abstract][Full Text] [Related]
32. Patterns of cervical cancer screening among Medicaid beneficiaries.
Dillon J; Chen L; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Wright JD
BJOG; 2022 Jun; 129(7):1104-1111. PubMed ID: 34882962
[TBL] [Abstract][Full Text] [Related]
33. Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion.
Huguet N; Angier H; Rdesinski R; Hoopes M; Marino M; Holderness H; DeVoe JE
Prev Med; 2019 Jul; 124():91-97. PubMed ID: 31077723
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries.
Pilon D; Patel C; Lafeuille MH; Zhdanava M; Lin D; Côté-Sergent A; Rossi C; Joshi K; Lefebvre P
Curr Med Res Opin; 2021 Oct; 37(10):1811-1819. PubMed ID: 34281472
[TBL] [Abstract][Full Text] [Related]
35. Factors Influencing Receipt of Interventional Pain Management Among Medicaid Beneficiaries with Cancer.
Halpern MT; Fiero MH
Pain Physician; 2019 May; 22(3):E147-E155. PubMed ID: 31151338
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
[TBL] [Abstract][Full Text] [Related]
37. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Womens Health Issues; 2010; 20(6):400-5. PubMed ID: 21050999
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity.
Domino ME; Beadles CA; Lichstein JC; Farley JF; Morrissey JP; Ellis AR; Dubard CA
Med Care; 2014 Mar; 52 Suppl 3():S101-9. PubMed ID: 24561748
[TBL] [Abstract][Full Text] [Related]
39. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
40. Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
Toboni MD; Cohen A; Gentry ZL; Ostby SA; Wang Z; Bae S; Leath C
Int J Gynecol Cancer; 2022 Jun; 32(6):724-731. PubMed ID: 35428687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
